Carotid atherosclerosis and serum lipoprotein(a) concentrations in patients with NIDDM

Diabetes Care

Volumn 20, Issue 5, 1997, Pages 829-831

  Yamamoto, Maki ^a   Egusa, Genshi ^a   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A;

ADULT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; INTIMA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0030999517     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.5.829     Document Type: Article

References (24)

1. Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hongaku H, Maeda H, Handa N, Matsumoto M, Kamada T: Prevalence of carotid atherosclerosis in diabetic patients. Diabetes Care 15:1290-1294, 1992
2. Visona A, Luisiani L, Bonanome A, Beltramello G, Confortin L, Papesso B, Costa F, Pagnan A: Wall thickening of common carotid arteries in patients affected by non insulin-dependent diabetes mellitus: relationship to microvascular complications. Angiology 46:793-799, 1995
3. McLean J, Tomlinson J, Kuang W, Eaton D, Chen E, Fless G, Lawn AS: cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330:132-137, 1987
4. Mbewu A, Durrington P: Lipoprotein(a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 85:1-14, 1990
5. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 59:199-204, 1986
6. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson G, Boerwinkle E, Utermann G: Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 322:1494-1499, 1990
7. Scanu A: Lipoprotein(a): a genetic risk factor for premature coronary heart disease. JAMA 267:3326-3329, 1992
8. Hiraga T, Sugimoto T, Kobayashi T, Ohashi Y, Okubo M, Murase T, Nakanishi K: Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. Diabetes Care 18:241-243, 1995
9. Jovicic A, Ivanisevic V, Ivanovic I: Lipoprotein(a) in patients with carotid atherosclerosis and ischemic cerebrovascular disorders. Atherosclerosis 98:59-65, 1993
10. Willeit J, Kiechl S, Santer P, Oberhollenzer F, Egger G, Jarosch E, Mair A: Lipoprotein(a) and asymptomatic carotid artery disease. Stroke 26:1582-1587, 1995
11. Pujia A, Gnasso A, Irace C, Colonnna A, Mattioli PL: Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care 17:1330-1336, 1994
12. Salonen J, Salonen R: Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 11:1245-1249, 1991
13. Ruiz J, Thillet J, Huby T, James R, Erlich D, Flandre P, Froguel P, Chapman J, Passa P: Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients: relationship with apolipoprotein(a) phenotypes. Diabetologia 37:585-591, 1994
14. Haffner S, Moss S, Klein B, Klein R: Lack of association between lipoprotein (a) concentration and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetes Retinopathy. Metabolism 41:194-197, 1992
15. Schernthaner G, Koster G, Dieplinger R, Prager R, Muhlhauser I: Apolipoprotein(A-1, A-2, B), Lp(a) lipoprotein and lecithin; cholesterol acyltransferase activity in diabetes mellitus. Atherosclerosis 49:277-293, 1983
16. Haffner S, Morales P, Stern M, Gruber M: Lp(a) concentrations in NIDDM. Diabetes 41:1267-1272, 1992
17. Nakata H, Horita K, Eto M: Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications. Metabolism 42:1323-1326, 1993
18. Kikuchi T, Boku A, Onuma T, Matsui J, Shimura M, Takebe K, Tsutsui M: Different change in lipoprotein(a) levels from lipid levels of other lipoproteins with improved glycemic control in patients with NIDDM. Diabetes Care 17:1059-1061, 1994
19. Garber AJ, Jones PH, Gahnem KK, Morrisett JD: Response of plasma lipoprotein (a) levels to diabetes control therapy. In Proc 9th International Symposium on Atherosclerosis (Abstract Book), 6-11 October 1991, Rosemont, IL. p. 12
20. Takegoshi T, Haba T, Hirai J, Kitou C, Saga T, Yamasaki Y, Mabuchi H: Alterations of lipoprotein(a) in patients with diabetic nephropathy. Atherosclerosis 83:99-100, 1990
21. Onuma T, Kikuchi T, Shimura M, Tsutsui M, Matsui J, Boku A, Takebe K: Lipoprotein(a) as an independent risk factor for diabetic retinopathy in male patients in non-insulin-dependent diabetes mellitus. J Exp Med 173:209-216, 1994
22. Seed M, O'Connor B, Perombelon N, O'Donnell M, Reavenley D, Knight B: The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover. Atherosclerosis 101:61-68, 1993
23. Sacks F, McPherson R, Walsh B: Effect of post menopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med 154:1106-1110, 1994
24. Sonnichsen A, Richler W Schwandt P: Reduction of lipoprotein(a) by weight loss. Int J Obes 14:487-494, 1990